Industry News
Monash IVF and RHS begin non-invasive PGS trial
Australian listed companies Monash IVF and RHS (Reproductive Health Science) have partnered to develop an accurate way to test for chromosome number in embryos without biopsy. [ + ]
Miele expands medical tech business with Steelco stake purchase
Miele is set to acquire a controlling stake in the Steelco Group to further expand in the medical technology industry. [ + ]
Prima says IMP321 trial progressing well
Prima BioMed has announced that the company's two active clinical trials in IMP321 are progressing well. [ + ]
Canadian CRO selected to reformulate cancer inhibitor
PharmAust has appointed contract research organisation BRI Pharmaceutical Research Inc to reformulate its lead drug candidate, Monepantel (MPL), for clinical trials. [ + ]
Cancer cells may streamline their genomes to replicate faster
A recent study, conducted in both human and mouse cells, has revealed that cancer cells might streamline their genomes in order to proliferate more easily. [ + ]
LBT Innovations completes CE mark certification for APAS
LBT Innovations and joint venture company Clever Culture Systems AG have completed a comprehensive essential requirements review of the extensive documentation and data packs related to the APAS technology and certify requirements are met for CE Marking. [ + ]
New medical cannabis body launched
A new industry body, the Medical Cannabis Council, has been launched with an aim to develop best practice and standards for producing, supplying and distributing medical cannabis. [ + ]
Genome regulation mystery solved
US researchers have addressed a longstanding question about how DNA functions are organised in space and time, including how genes are regulated to be silenced or expressed. [ + ]
Lab Innovations 2017
Lab Innovations, the UK's dedicated show for laboratory technology, analytical and biotech equipment, returns for its sixth consecutive year from 1–2 November 2017 at the NEC, Birmingham. [ + ]
Clinical trials provide $1.1bn to economy
Clinical trials accounted for roughly $1.1 billion in gross expenditure in 2015, and the annual expenditure could reach 2 billion in the next 10 years. [ + ]
When immune cells turn toxic
A subpopulation of immune cells that normally fend off pathogens can turn against the host during certain infections, an international research team has revealed. [ + ]
Genetic Signatures receives regulatory approval for Enteric products
Molecular diagnostics company Genetic Signatures has received Australian and European regulatory approval for its Enteric Viral Detection solution. This will allow the sale of the company's complete enteric suite within those regions, which represent 22% of the global molecular diagnostics market. [ + ]
The week in medical cannabis: ethics approval granted, new JV formed
It's been a big week for Australia's growing medical cannabis industry, with ethics approval granted for two human trials as well as the formation of a new joint venture. [ + ]
Faster diagnosis of antibiotic-resistant infections
Australian researchers have pioneered a faster method for finding the best antibiotic to treat an infection, in a breakthrough with the potential to save lives and preserve the usefulness of antibiotics. [ + ]
Cancer start-up receives US$16m funding
QUE Oncology, a clinical-stage biotechnology company established by The University of Queensland and Emory University (Atlanta, USA), has received US$16 million in series A investment. [ + ]
